Papers - NAKAMURA NORIO
-
Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis.
Nakamura N, Kumasaka R, Osawa H, Yamabe H, Shirato K, Fujita T, Murakami R, Shimada M, Nakamura M, Okumura K, Hamazaki K, Hamazaki T.
In Vivo 2005.5
-
Effects of cilostazol on lipid and fatty acid metabolism.
Nakamura N, Osawa H, Yamabe H, Okumura K, Hamazaki T.
Clin Exp Med 2005.5
-
Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy.
Kumasaka R, Nakamura N, Shirato K, Osawa H, Takanashi S, Hasegawa Y, Yamabe H, Nakamura M, Tamura M, Okumura K
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22 ( 12 ) 2504 - 5 2004.6
-
Nephrotic syndrome associated with gefitinib therapy.
Kumasaka R, Nakamura N, Shirato K, Osawa H, Takanashi S, Hasegawa Y, Yamabe H, Nakamura M, Tamura M, Okumura K.
J Clin Oncol 2004.6
-
Thrombin stimulates production of fibronectin by human proximal tubular epithelial cells via a transforming growth factor--dependent mechanism.
Shirato K, Osawa H, Kaizuka M, Nakamura N, Sugawara T, Nakamura M, Tamura M, Yamabe H, Okumura K.
Nephrol Dial Transplant 2003.11
-
Thrombin stimulates production of fibronectin by human proximal tubular epithelial cells via a transforming growth factor-beta-dependent mechanism.
Shirato K, Osawa H, Kaizuka M, Nakamura N, Sugawara T, Nakamura M, Tamura M, Yamabe H, Okumura K
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 18 ( 11 ) 2248 - 54 2003.11
-
Angioedema Associated with Eosinophilia
YAMABE Hideaki, TAKANASHI Shingo, OSAWA Hiroshi, NAKAMURA Norio, SHIRATO Kenichi, SUGAWARA Toshiyuki, NAKAMURA Masayuki, TAMURA Michiko, OKUMURA Ken
Internal medicine 42 ( 7 ) 626 2003.7
-
Angioedema Associated with Eosinophilia.
Yamabe H, Takanasi S, Osawa H, Nakamura N, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K.
Internal Medicine 2003.7
-
Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes.
Nakamura N, Yamazaki K, Satoh A, Urakaze M, Kobayashi M, Yamabe H, Osawa H, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K.
In vivo 2003.4
-
Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes.
Nakamura N, Yamazaki K, Satoh A, Urakaze M, Kobayashi M, Yamabe H, Osawa H, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K
In vivo (Athens, Greece) 17 ( 2 ) 177 - 80 2003.3
-
Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular disease.
Nakamura N, Hamazaki T, Johkaji H, Minami S, Yamazaki K, Satoh A, Sawazaki S, Urakaze M, Kobayashi M, Osawa H, Yamabe H, Okumura K.
Clin Exp Med 2003.2
-
Platelet-derived growth factor stimulates matrix metalloproteinase-2 secretion in cultured human mesangial cells
OSAWA Hiroshi, YAMABE Hideaki, KAIZUKA Mitsuaki, NAKAMURA Norio, SHIRATO Ken-ichi, SUGAWARA Toshiyuki, NAKAMURA Masayuki, TAMURA Michiko, OKUMURA Ken
Clinical and experimental nephrology 6 ( 4 ) 202 - 206 2002.12